Date | Name | Title | Type | Security | Shares | Price | Value | Ownership | Reported |
11/14/2022 | BERGER FRANKLIN M | Director | Sale | Common Stock | 16.2k | $5.16 | $83.4k | | 11/11/2022 |
11/11/2022 | BERGER FRANKLIN M | Director | Sale | Common Stock | 25.5k | $5.15 | $131.3k | | 11/11/2022 |
06/17/2022 | Murphy Polly A. | Director | Grant | Stock Option (Right to Buy) | 61.3k | $6.50 | $398.2k | | 06/17/2022 |
06/17/2022 | Duncan Barbara Gayle | Director | Grant | Stock Option (Right to Buy) | 61.3k | $6.50 | $398.2k | | 06/17/2022 |
06/17/2022 | Lucidi Bruno | Director | Grant | Stock Option (Right to Buy) | 61.3k | $6.50 | $398.2k | | 06/17/2022 |
06/17/2022 | Adams Jerome M. | Director | Grant | Stock Option (Right to Buy) | 61.3k | $6.50 | $398.2k | | 06/17/2022 |
06/17/2022 | BERGER FRANKLIN M | Director | Grant | Stock Option (Right to Buy) | 61.3k | $6.50 | $398.2k | | 06/17/2022 |
06/17/2022 | Polsky Bruce | Director | Grant | Stock Option (Right to Buy) | 61.3k | $6.50 | $398.2k | | 06/17/2022 |
01/31/2022 | Sommadossi Jean-Pierre | President, CEO, and Chairman | Grant | Stock Option (Right to Buy) | 378k | $7.14 | $2.7M | | 01/31/2022 |
01/31/2022 | Corcoran Andrea | See Remarks | Grant | Stock Option (Right to Buy) | 181k | $7.14 | $1.3M | | 01/31/2022 |
01/31/2022 | Vavricka John | Chief Commercial Officer | Grant | Stock Option (Right to Buy) | 135k | $7.14 | $963.9k | | 01/31/2022 |
01/31/2022 | Horga Maria Arantxa | Chief Medical Officer | Grant | Stock Option (Right to Buy) | 170k | $7.14 | $1.2M | | 01/31/2022 |
01/31/2022 | Hammond Janet MJ | Chief Development Officer | Grant | Stock Option (Right to Buy) | 190k | $7.14 | $1.4M | | 01/31/2022 |
01/31/2022 | Foster Wayne | EVP, Chief Accounting Officer | Grant | Stock Option (Right to Buy) | 120k | $7.14 | $856.8k | | 01/31/2022 |
12/20/2021 | Murphy Polly A. | Director | Purchase | Common Stock | 12k | $8.57 | $102.8k | | 12/20/2021 |
06/18/2021 | Duncan Barbara Gayle | Director | Grant | Stock Option (Right to Buy) | 34k | $23.39 | $795.8k | | 06/18/2021 |
06/18/2021 | Lucidi Bruno | Director | Grant | Stock Option (Right to Buy) | 34k | $23.39 | $795.8k | | 06/18/2021 |
06/18/2021 | Murphy Polly A. | Director | Grant | Stock Option (Right to Buy) | 34k | $23.39 | $795.8k | | 06/18/2021 |
06/18/2021 | BERGER FRANKLIN M | Director | Grant | Stock Option (Right to Buy) | 34k | $23.39 | $795.8k | | 06/18/2021 |
06/18/2021 | Polsky Bruce | Director | Grant | Stock Option (Right to Buy) | 34k | $23.39 | $795.8k | | 06/18/2021 |
05/18/2021 | Adams Jerome M. | Director | Grant | Stock Option (Right to Buy) | 56.7k | $23.43 | $1.3M | | 05/18/2021 |
01/29/2021 | Vavricka John | Chief Commercial Officer | Grant | Stock Option (Right to Buy) | 117.3k | $73.00 | $8.6M | | 01/29/2021 |
01/29/2021 | Horga Maria Arantxa | Chief Medical Officer | Grant | Stock Option (Right to Buy) | 145.5k | $73.00 | $10.6M | | 01/29/2021 |
01/29/2021 | Corcoran Andrea | See Remarks | Grant | Stock Option (Right to Buy) | 148.8k | $73.00 | $10.9M | | 01/29/2021 |
01/29/2021 | Hammond Janet MJ | Chief Development Officer | Grant | Stock Option (Right to Buy) | 160k | $73.00 | $11.7M | | 01/29/2021 |
01/29/2021 | Foster Wayne | EVP, Chief Accounting Officer | Grant | Stock Option (Right to Buy) | 71.8k | $73.00 | $5.2M | | 01/29/2021 |
01/29/2021 | Sommadossi Jean-Pierre | President, CEO, and Chairman | Grant | Stock Option (Right to Buy) | 640k | $73.00 | $46.7M | | 01/29/2021 |
11/03/2020 | Sommadossi Jean-Pierre | President, CEO, and Chairman | Conversion | Common Stock | 750k | $0.00 | $0 | Held by JPM Partners LLC | 11/03/2020 |
11/03/2020 | Sommadossi Jean-Pierre | President, CEO, and Chairman | Conversion | Series A Convertible Preferred Stock | 750k | $0.00 | $0 | Held by JPM Partners LLC | 11/03/2020 |
11/03/2020 | BERGER FRANKLIN M | Director | Conversion | Common Stock | 759.6k | $0.00 | $0 | | 11/03/2020 |
11/03/2020 | BERGER FRANKLIN M | Director | Purchase | Common Stock | 41.7k | $24.00 | $1000k | | 11/03/2020 |
11/03/2020 | BERGER FRANKLIN M | Director | Conversion | Series A Convertible Preferred Stock | 400k | $0.00 | $0 | | 11/03/2020 |
11/03/2020 | BERGER FRANKLIN M | Director | Conversion | Series B Convertible Preferred Stock | 132k | $0.00 | $0 | | 11/03/2020 |
11/03/2020 | BERGER FRANKLIN M | Director | Conversion | Series C Convertible Preferred Stock | 131.6k | $0.00 | $0 | | 11/03/2020 |
11/03/2020 | BERGER FRANKLIN M | Director | Conversion | Series D Convertible Preferred Stock | 60.5k | $0.00 | $0 | | 11/03/2020 |
|